RESUMO
With 1st case being reported in Wuhan city of China in December 2019, COVID?19 infection cases made their way to every corner of the world. Then, on January 07, 2020, laboratory results led to pneumonia being named as COVID?19. Scant data is available from Northern India, thus to reveal the trend of COVID?19 infection since last year of COVID?19 pandemic onset, this study took shape. The unit of analysis of our study was District Anantnag, Jammu and Kashmir. Till February 05, 2021, a total of 4625 cases of COVID?19 virus were reported in District Anantnag, Jammu and Kashmir. Negative history of close contact with COVID?19 patient (66.1%) constituted the most common exposure, majority (84.4%) were asymptomatic and comorbidities were present in 68 (1.5%). COVID?19 infection was more prevalent among younger age group, with higher male predominance, with comorbid being at higher risk, hence most stringent measures must be adopted.
RESUMO
Recent technological advances in cataract surgery with small incision ensure less surgically induced astigmatism and faster visual rehabilitation .Manual small incision non phaco surgery has added advantage of low cost and less machine dependence. We present a series of 115 patients who were operated upon using manual small incision cataract surgery and studied for visual recovery. 95.65% of patients achieved a best corrected visual acuity of 6/12 or better and the mean surgically induced astigmatism at 3 months was 0.69 Diopters .
RESUMO
This study was designed to evaluate the possible complications following the use of intraoperative mitomycin-C in patients undergoing surgery for primary pterygium. Hundred eyes of 88 patients with primary pterygium were operated upon using ''bare sclera technique''. Intraoperatively all the patients were applied freshly prepared mitomycin-C 0.02% (0.2 mg/ml) on the bare sclera for a period of 5 minutes, after which the eyes were thoroughly rinsed with a sterile balanced salt solution. Postoperatively, none of the patients recieved mitomycin-C eye drops. After a mean postoperative followup of 14 months, 4 eyes (4%) of 4 patients developed thinning of the sclera with visualization of the underlying uveal tissue. One eye (1%) developed extreme thinning of the sclera with ectasia of the underlying uveal tissue, requiring a scleral patch. Recurrence was seen in 2 eyes (2%) only. The study shows that although intraoperative mitomycin-C (0.02%) reduces the recurrence of pterygium, it leads to serious, cosmetically unacceptable and even sight-threatening complications.